Skip to main content

News and Events


This section displays the selected news item. Show all news items.

University of Warwick recognised by Bill Gates for work to combat neglected tropical diseases

image

Bill Gates, co-chair of the Bill & Melinda Gates Foundation, has recognised the work being done by the University of Warwick to combat neglected tropical diseases (NTDs) in a speech at the Geneva Summit on NTDs.

NTDs are some of the oldest and most painful diseases afflicting the world’s poorest communities. One in six people suffer from NTDs worldwide, including more than half a billion children.

The University was recently awarded $3 million in funding from the Foundation for the Warwick-led NTD Modelling Consortium, which draws together 12 research institutes from around the world to provide quantitative data on the prevalence of NTDs and the impact of intervention programmes.

Warwick Ventures assisted with the Consortium’s application to the Foundation, including supplying information on background intellectual property and outlining an IP management plan for the project.

In recognising the University of Warwick’s contribution, Mr Gates said: “UK aid and Britain’s world-leading research institutions like the University of Warwick are playing a major role in protecting the world’s poorest people from Neglected Tropical Diseases and enabling them to live healthier, more prosperous lives.”

Dr Deirdre Hollingsworth, who is leading the consortium from the School of Life Sciences and the Mathematics Institute at the University of Warwick, said: “It is fantastic to be involved with such an exciting and worthwhile project that give the international modelling community the opportunity to demonstrate its expertise and commitment to NTDs. There are significant scientific challenges to producing quantitative frameworks that can support the effort to control NTDs but, through this unique partnership, we will be ready for them.”

Find out more about the NTD Modelling Consortium

Wed 26 April 2017, 15:12 | Tags: Warwick Ventures, Life Sciences and Biotechnology